Skip to content

Clinical trials

Endometrial Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Country / region: Singapore Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20122
20141
20151
20203
20212
20223
20231
20242
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Active, not recruiting7
Completed4
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
ARCAGY/ GINECO GROUP1
Atavistik Bio, Inc1
BioNTech SE1
Byondis B.V.1
EDDC (Experimental Drug Development Centre), A*STAR Research Entities1
Eikon Therapeutics1
Genmab1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms22
Ovarian Neoplasms7
Breast Neoplasms5
Neoplasm Metastasis5
Uterine Cervical Neoplasms5
Uterine Neoplasms4
Lung Neoplasms3
Triple Negative Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.